| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Geoffrey Lynn | Chief Scientific Officer | $1,560,994 | 17 Dec 2024 | ||
| Christopher Ellis | Chief Operating Officer | $183 | 03 Jan 2023 | ||
| Pierre A. Morgon | Director | 10 Jun 2025 | |||
| Nadege Pelletier | Chief Scientific Officer | 02 Jan 2024 | |||
| KAREN A. DAWES | Director | 10 Jun 2025 | |||
| Anne M. Phillips | Director | 10 Jun 2025 | |||
| William Enright | Chief Executive Officer, Director | 03 Feb 2025 | |||
| Joseph Scheeren | Director | 10 Jun 2025 | |||
| Alex Hammacher | Director | 10 Jun 2025 | |||
| Leon Hooftman | Chief Medical Officer | 03 Feb 2025 | |||
| Robin Wright | Director | 10 Jun 2025 | |||
| Graham Griffiths | Chief Business Officer | 03 Feb 2025 | |||
| Gemma Brown | Chief Financial Officer | 03 Feb 2025 | |||
| Thomas George Evans | Fmr Chief Scientific Officer | 03 Jan 2023 | |||
| M&G INVESTMENT MANAGEMENT LTD | 10%+ Owner | 30 Sep 2022 | |||
| Georgy Egorov | Chief Financial Officer | 03 Jan 2022 | |||
| M&G Alternatives Investment Management Ltd | 10%+ Owner | 30 Sep 2022 | |||
| Margaret Marshall | Chief Medical Officer | 03 Jan 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|